Andersons pediatric cardiology 1698
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (59.7 KB, 3 trang )
ofchildhoodandadolescentcancer:
retrospectiveanalysisofthechildhoodcancer
survivorstudycohort.BrMed
J.2009;339:b4606.
ReportfromtheCCSScohortthatestablishedrates
ofCTCinsurvivorsofpediatriccancerfor
severaldecadesaftertreatmentandservesasthe
basisofseveralsubsequentstudies..
PlanaJC,GalderisiM,BaracA,etal.Expert
consensusformultimodalityimagingevaluation
ofadultpatientsduringandaftercancertherapy:
areportfromtheAmericansocietyof
echocardiographyandtheEuropeanassociation
ofcardiovascularimaging.JAmSoc
Echocardiogr.2014;27(9):911–939.
AmericanSocietyofEchocardiography
recommendationsforfollowingadultpatients
duringandaftercancertherapy,withuseof
imagingandserumbiomarkers..
ShaikhF,DupuisLL,AlexanderS,GuptaA,
MertensL,NathanPC.Cardioprotectionand
secondmalignantneoplasmsassociatedwith
dexrazoxaneinchildrenreceivinganthracycline
chemotherapy:asystematicreviewandmetaanalysis.JNatlCancerInst.2016;108(4).
Meta-analysisconcludingthatthebalanceofrisk
forCTCversussecondarymalignantneoplasms
shouldbeconsideredinmakingthedecisionof
whethertousedexrazoxaneinpediatriccancer
populations..
ThavendiranathanP,PoulinF,LimKD,PlanaJC,
WooA,MarwickTH.Useofmyocardialstrain
imagingbyechocardiographyfortheearly
detectionofcardiotoxicityinpatientsduringand
aftercancerchemotherapy:asystematicreview.
JAmCollCardiol.2014;63(25PtA):2751–2768.
Comprehensivereviewofmyocardialstrain
imaging(echocardiography)inpatientsforthe
earlydetectionofCTC.Includedarereviewsof
severalpediatricstudies..
vanDalenEC,vanderPalHJ,KremerLC.
Differentdosageschedulesforreducing
cardiotoxicityinpeoplewithcancerreceiving
anthracyclinechemotherapy.Cochrane
DatabaseSystReviews.2016;(3)[CD005008].
Systematicreviewofvariabledosingschedulesand
alternateanthracyclineformulationsin
preventingCTC.Longerinfusiontimeand
liposomal-encapsulateddoxorubicinwerefound
protective,howeveradultpopulationsmadeup
themajorityofthestudies..
ZamoranoJL,LancellottiP,RodriguezMunozD,
etal.2016ESCpositionpaperoncancer
treatmentsandcardiovasculartoxicitydeveloped
undertheauspicesoftheESCcommitteefor
practiceguidelines:thetaskforceforcancer
treatmentsandcardiovasculartoxicityofthe
Europeansocietyofcardiology(ESC).Eur
HeartJ.2016;37(36):2768–2801.
Detailedandspecificguidelinesformanagementof
CTCinadultpatients,producedbythe
EuropeanSocietyofCardiology..
